I. Reid

D. Bauer, I. Reid, K. Ensrud, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Zoledronate.

S. Cummings, I. Reid, D. Reid, 2020, Bone.

Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure

S. Boonen, I. Reid, P. Delmas, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Genome-Wide Association Study Using Extreme Truncate Selection Identifies Novel Genes Affecting Bone Mineral Density and Fracture Risk

Steve D. M. Brown, Roger D. Cox, Rajesh V. Thakker, 2011, PLoS genetics.

Effects of Calcium Supplementation on Circulating Lipids

I. Reid, 2004, Drugs & aging.

Management: Established Osteoporosis in Organ Transplant Recipients

I. Reid, 2005 .

Comment: Assessing the Potential Adverse Consequences of Supplemental Calcium on Cardiovascular Outcomes: Should We Change Our Approach to Bone Health?

I. Reid, A. Grey, M. Bolland, 2012, The Annals of pharmacotherapy.

Parathyroid hormone reflects adiposity and cardiometabolic indices but not bone density in normal men.

I. Reid, G. Gamble, E. Billington, 2016, BoneKEy reports.

Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

Claus Christiansen, Cesar Libanati, Michael R McClung, 2009, The New England journal of medicine.

Emerging issues with bisphosphonates.

I. Reid, 2006, Rheumatic diseases clinics of North America.

Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5‐Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open‐Label Extension of a Randomized Controlled Trial

I. Reid, G. Gamble, A. Grey, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Calcium intake and risk of fracture: systematic review

I. Reid, G. Gamble, William Leung, 2015, BMJ : British Medical Journal.

Calcium intake and bone mineral density: systematic review and meta-analysis

I. Reid, William Leung, A. Grey, 2015, BMJ : British Medical Journal.

The anti‐oestrogen tamoxifen produces haemodilution in normal postmenopausal women

I. Reid, A. Grey, M. Evans, 1997, Journal of internal medicine.

Circulating calcium concentrations, vascular disease and mortality: a systematic review

I. Reid, G. Gamble, M. Bolland, 2016, Journal of internal medicine.

Bone-Bound Bisphosphonates Inhibit Proliferation of Breast Cancer Cells

I. Reid, J. Cornish, U. Bava, 2019, Calcified Tissue International.

Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women.

I. Reid, R. Ames, G. Gamble, 2006, Bone.

The effect of atorvastatin on markers of bone turnover in patients with type 2 diabetes.

I. Reid, G. Gamble, W. Bagg, 2004, Bone.

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.

I. Reid, A. Tonkin, J. Emberson, 2001, Lancet.

Effects of beta-blockers on fracture risk.

I. Reid, 2008, Journal of musculoskeletal & neuronal interactions.

Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo.

I. Reid, J. Cornish, K. Callon, 1997, American journal of physiology. Endocrinology and metabolism.

A potential role for adrenomedullin as a local regulator of bone growth.

I. Reid, J. Cornish, K. Callon, 2001, Endocrinology.

Osteoporosis: evidence for vitamin D and calcium in older people

I. Reid, 2020, Drug and Therapeutics Bulletin.

Calcium and/or Vitamin D Supplementation for the Prevention of Fragility Fractures: Who Needs It?

I. Reid, M. Bolland, 2020, Nutrients.

Calcium and Bone.

I. Reid, S. Bristow, 2019, Handbook of experimental pharmacology.

Calcium and vitamin D: To supplement or not?

I. Reid, 2018, Cleveland Clinic Journal of Medicine.

Controversies in osteoporosis management

I. Reid, 2016, Internal medicine journal.

Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis?

I. Reid, A. Grey, M. Bolland, 2015, Climacteric : the journal of the International Menopause Society.

Efficacy, effectiveness and side effects of medications used to prevent fractures

I. Reid, 2015, Journal of internal medicine.

Calcium intake and bone mineral density: systematic review

I. Reid, William Leung, A. Grey, 2015 .

Vitamin D and its Metabolites and Analogs in the Management of Osteoporosis

I. Reid, R. Bouillon, 2013 .

Cardiovascular Effects of Calcium Supplements

I. Reid, 2013, Nutrients.

Osteoporosis treatment: focus on safety.

I. Reid, 2013, European journal of internal medicine.

The impact of dietary calcium intake and vitamin D status on the effects of zoledronate

I. Reid, G. Gamble, A. Grey, 2012, Osteoporosis International.

Calcium supplementation: balancing the cardiovascular risks.

I. Reid, P. Sambrook, A. Grey, 2011, Maturitas.

Cardiovascular effects of calcium supplementation

A. Avenell, I. Reid, A. Grey, 2011, Osteoporosis International.

Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism.

I. Reid, A. Grey, P. Browett, 2006, The New England journal of medicine.

Age‐, gender‐, and weight‐related effects on levels of 25‐hydroxyvitamin D are not mediated by vitamin D binding protein

I. Reid, R. Ames, G. Gamble, 2007, Clinical endocrinology.

Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2000, The American journal of medicine.

Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.

Jacques P. Brown, C. Cooper, M. Bhandari, 2017, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

Jacques P. Brown, C. Cooper, M. Bhandari, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Modulation of osteoclastogenesis by fatty acids.

I. Reid, J. Cornish, K. Callon, 2008, Endocrinology.

Osteoporosis: non-HRT treatments

I. Reid, 2002 .

Pharmacological Management of Osteoporosis in Postmenopausal Women

I. Reid, 1999, Drugs & aging.

The management of osteoporosis.

I. Reid, 1997, Bailliere's clinical endocrinology and metabolism.

Cardiovascular endocrinology: Controversy—cardiovascular effects of calcium supplementation

I. Reid, 2014, Nature Reviews Endocrinology.

Acute effects of calcium supplements on blood pressure: randomised, crossover trial in postmenopausal women

I. Reid, G. Gamble, A. Horne, 2016, Osteoporosis International.

Randomized controlled trial of calcium in healthy older women.

I. Reid, R. Ames, G. Gamble, 2006, The American journal of medicine.

Vitamin D Effect on Bone Mineral Density and Fractures.

I. Reid, 2017, Endocrinology and metabolism clinics of North America.

What diseases are causally linked to vitamin D deficiency?

I. Reid, 2015, Archives of Disease in Childhood.

Calcium supplements: benefits and risks

I. Reid, M. Bolland, S. Bristow, 2015, Journal of internal medicine.

Benefits of Calcium Supplements Are Too Small for Clinical Equipoise to Exist

I. Reid, A. Grey, M. Bolland, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women.

I. Reid, G. Gamble, A. Horne, 2014, The British journal of nutrition.

Vitamin D: Present and future.

I. Reid, 2014, Revista clinica espanola.

Effects of vitamin D supplements on bone density

I. Reid, 2014, Journal of Endocrinological Investigation.

Response to letter to editor

I. Reid, M. Bolland, 2014, Osteoporosis International.

Calcium risk-benefit updated--new WHI analyses.

I. Reid, M. Bolland, 2014, Maturitas.

The Auckland calcium study: 5-year post-trial follow-up

I. Reid, G. Gamble, A. Grey, 2013, Osteoporosis International.

Calcium supplements: bad for the heart?

I. Reid, M. Bolland, 2012, Heart.

Should measurement of vitamin D and treatment of vitamin D insufficiency be routine in New Zealand?

I. Reid, A. Grey, T. Cundy, 2012, The New Zealand medical journal.

Risk factors: Calcium supplements and cardiovascular risk

I. Reid, M. Bolland, 2012, Nature Reviews Cardiology.

Authors’ response to editorial

I. Reid, A. Grey, M. Bolland, 2011, BMJ : British Medical Journal.

Evidence‐based policy on dietary calcium and vitamin D

A. Avenell, I. Reid, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Does calcium supplementation increase cardiovascular risk?

I. Reid, A. Grey, M. Bolland, 2010, Clinical endocrinology.

Vitamin D supplementation.

I. Reid, A. Grey, M. Bolland, 2010, Archives of internal medicine.

Calcium supplementation for older men and women?

I. Reid, A. Grey, M. Bolland, 2009, Osteoporosis International.

Effect of calcium supplementation on hip fractures

I. Reid, A. Grey, M. Bolland, 2008, Osteoporosis International.

Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men.

I. Reid, R. Ames, G. Gamble, 2008, Archives of internal medicine.

Calcium supplementation does not increase mortality

I. Reid, A. Grey, M. Bolland, 2008, The Medical journal of Australia.

Anti-resorptive therapies for osteoporosis.

I. Reid, 2008, Seminars in cell & developmental biology.

randomised controlled trial receiving calcium supplementation: Vascular events in healthy older women

P. Barber, R. Doughty, I. Reid, 2008 .

Effect of calcium supplementation on bone loss in postmenopausal women.

I. Reid, R. Ames, G. Gamble, 1993, The New England journal of medicine.

High-dose oral vitamin D3 supplementation in the elderly

I. Reid, G. Gamble, C. Bacon, 2009, Osteoporosis International.

Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety

I. Reid, 2002, Expert opinion on drug safety.

Comparison of the Effects of Calcitonin Gene‐Related Peptide and Amylin on Osteoblasts

I. Reid, J. Cornish, K. Callon, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Differences between the bisphosphonates for the prevention and treatment of osteoporosis

I. Reid, A. Grey, 2006, Therapeutics and clinical risk management.

Alteration of bone cell function by RANKL and OPG in different in vitro models

I. Reid, J. Cornish, K. Callon, 2007, European journal of clinical investigation.

Decreased bone density in men on methadone maintenance therapy.

I. Reid, G. Gamble, A. Grey, 2011, Addiction.

Prolonged antiresorptive activity of zoledronate: A randomized, controlled trial

I. Reid, G. Gamble, A. Grey, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Relationships among body mass, its components, and bone.

I. Reid, 2002, Bone.

Long-Term Effects of Calcium Supplementation on Bone Loss and Fractures in Postmenopausal Women: A Randomized Controlled Trial

I. Reid, R. Ames, G. Gamble, 1995 .

Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency.

I. Reid, R. Ames, G. Gamble, 2003, The New Zealand medical journal.

Evidence for anti-osteoporosis therapy in acute fracture situations--recommendations of a multidisciplinary workshop of the International Society for Fracture Repair.

J. Goldhahn, I. Reid, D. Marsh, 2010, Bone.

Vitamin D and Its Metabolites in the Management of Osteoporosis

I. Reid, 2001 .

Determinants of the rate of bone loss in normal postmenopausal women.

I. Reid, R. Ames, G. Gamble, 1994, The Journal of clinical endocrinology and metabolism.

The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women.

I. Reid, R. Ames, A. Grey, 1995, The American journal of medicine.

Calcium and cardiovascular risks

I. Reid, A. Grey, M. Bolland, 2013 .

Elevated Urate Levels Do Not Alter Bone Turnover Markers: Randomized Controlled Trial of Inosine Supplementation in Postmenopausal Women

T. Merriman, I. Reid, G. Gamble, 2021, Arthritis & rheumatology.

Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells.

I. Reid, J. Cornish, K. Callon, 2003, Endocrinology.

Morbidity and mortality in mild primary hyperparathyroidism

I. Reid, A. Grey, M. Bolland, 2010, Clinical endocrinology.

Association between primary hyperparathyroidism and increased body weight: a meta-analysis.

I. Reid, G. Gamble, A. Grey, 2005, The Journal of clinical endocrinology and metabolism.

Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy.

I. Reid, S. Heap, S. Heap, 1990, Archives of internal medicine.

The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON‐Pivotal Fracture Trial (PFT)

S. Cummings, J. Cauley, I. Reid, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Denosumab after 8 years

I. Reid, 2015, Osteoporosis International.

Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial.

I. Reid, G. Gamble, A. Grey, 2012, The Journal of clinical endocrinology and metabolism.

Time to onset of antifracture efficacy and year‐by‐year persistence of effect of zoledronic acid in women with osteoporosis

S. Boonen, J. Cauley, I. Reid, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies

I. Reid, 2011, Skeletal Radiology.

Steroid-induced osteoporosis

I. Reid, 2010, Osteoporosis International.

Chapter 18 – Bisphosphonates in the Prevention and Treatment of Postmenopausal Osteoporosis

I. Reid, 2006 .

Intravenous zoledronic acid in postmenopausal women with low bone mineral density.

Jacques P. Brown, D. Felsenberg, J. Kaufman, 2002, The New England journal of medicine.

Prevention of hip fractures with risedronate

I. Reid, 2001 .

Osteoporosis--emerging consensus.

I. Reid, 1997, Australian and New Zealand journal of medicine.

Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post‐menopausal osteoporosis

I. Reid, M. Evans, D. Wattie, 1997, Clinical endocrinology.

Anti-fracture efficacy of hormone replacement therapy

I. Reid, 2001 .

Therapy of osteoporosis: calcium, vitamin D, and exercise.

I. Reid, 1996, The American journal of the medical sciences.

Vitamin D – let's get back to the evidence base

I. Reid, 2010 .

The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis.

I. Reid, G. Gamble, A. Grey, 2014, The lancet. Diabetes & endocrinology.

Determinants of total body and regional bone mineral density in normal postmenopausal women--a key role for fat mass.

I. Reid, R. Ames, G. Gamble, 1992, The Journal of clinical endocrinology and metabolism.

Testosterone therapy in glucocorticoid-treated men.

I. Reid, M. Evans, J. Stapleton, 1996 .

Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis.

I. Reid, G. Gamble, J. Cornish, 1994, The Journal of clinical endocrinology and metabolism.

Body Weight and Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism

I. Reid, A. Grey, M. Evans, 1994, Annals of Internal Medicine.

Lateral spine densitometry is a more sensitive indicator of glucocorticoid‐induced bone loss

I. Reid, M. Evans, J. Stapleton, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

What factors modify the effect of monthly bolus dose vitamin D supplementation on 25-hydroxyvitamin D concentrations?

I. Reid, C. Lawes, C. Camargo, 2020, The Journal of Steroid Biochemistry and Molecular Biology.

Calcium supplementation and vascular disease

I. Reid, M. Bolland, 2008, Climacteric : the journal of the International Menopause Society.

Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2002, The American journal of medicine.

Nitrates Do Not Affect Bone Density or Bone Turnover in Postmenopausal Women: A Randomized Controlled Trial

I. Reid, G. Gamble, A. Grey, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Targeting Sclerostin in Postmenopausal Osteoporosis: Focus on Romosozumab and Blosozumab

I. Reid, 2017, BioDrugs.

Observational studies—just telling us what we want to hear or telling us where we need to look?

I. Reid, M. Bolland, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Abnormal cell calcium concentrations in cultured bone cells obtained from femurs of obese and noninsulin-dependent diabetic rats

I. Reid, L. Avioli, J. Gavin, 1989, Calcified Tissue International.

Epidemiology and pathogenesis of osteonecrosis of the jaw

I. Reid, J. Cornish, 2012, Nature Reviews Rheumatology.

Randomized, active-controlled study of once-weekly alendronate 280 mg high dose oral buffered solution for treatment of Paget’s disease

I. Reid, D. Hosking, P. Selby, 2008, Osteoporosis International.

The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women.

I. Reid, A. Grey, M. Evans, 1995, The Journal of clinical endocrinology and metabolism.

Vitamin D insufficiency and health outcomes over 5 y in older women.

I. Reid, R. Ames, G. Gamble, 2010, The American journal of clinical nutrition.

Vitamin D insufficiency and health outcomes over 5 y in older women 1 – 3

I. Reid, R. Ames, G. Gamble, 2009 .

– Systematic with Meta-Analysis Calcium supplements and cancer risk : a meta-analysis of randomised controlled trials

A. Avenell, I. Reid, G. Gamble, 2013 .

Systematic Review with Meta-Analysis Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials

A. Avenell, I. Reid, G. Gamble, 2013 .

Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials.

A. Avenell, I. Reid, G. Gamble, 2013, The British journal of nutrition.

Nutrition and bone health: the case of selenium

I. Reid, 2021, The Lancet Healthy Longevity.

Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trial

I. Reid, G. Gamble, A. Grey, 2017, Canadian Medical Association Journal.

Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams.

S. Boonen, I. Reid, R. Eastell, 2013, The Journal of clinical endocrinology and metabolism.

Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men.

I. Reid, G. Gamble, A. Grey, 2012, The Journal of clinical endocrinology and metabolism.

Longitudinal changes in bone mineral density, bone mineral content and bone area at the lumbar spine and hip in postmenopausal women, and the influence of abdominal aortic calcification

I. Reid, G. Gamble, A. Horne, 2018, Bone reports.

Bisphosphonates: new indications and methods of administration

I. Reid, 2003, Current opinion in rheumatology.

Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post‐menopausal women

I. Reid, A. Grey, T. Cundy, 1996, Clinical endocrinology.

Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post‐menopausal osteoporosis

I. Reid, A. Grey, T. Cundy, 1994, Clinical endocrinology.

CHAPTER 71 – Vitamin D and its Metabolites and Analogs in the Management of Osteoporosis

I. Reid, R. Bouillon, 2008 .

PATHOGENESIS AND TREATMENT OF STEROID OSTEOPOROSIS

I. Reid, 1989, Clinical endocrinology.

Calcium supplements in the prevention of steroid-induced osteoporosis.

I. Reid, H. Ibbertson, 1986, The American journal of clinical nutrition.

Prospective 10‐year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy

I. Reid, R. Ames, G. Gamble, 2002, Clinical endocrinology.

Bone mineral density and body composition in adult patients with cystic fibrosis.

I. Reid, R. Ames, A. Grey, 1993, Thorax.

Calcium sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal women.

I. Reid, R. Ames, G. Gamble, 2003, The Journal of clinical endocrinology and metabolism.

Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients

I. Reid, R. Ames, T. Cundy, 1992, Osteoporosis International.

Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial.

W. Murphy, I. Reid, R. Weinstein, 1996, The American journal of medicine.

Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception.

I. Reid, J. Cornish, T. Cundy, 2002, American journal of obstetrics and gynecology.

Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region

I. Reid, A. Mithal, P. Ebeling, 2021, Osteoporosis International.

Differences in hip axis and femoral neck length in premenopausal women of Polynesian, Asian and European origin

I. Reid, J. Cornish, T. Cundy, 2005, Osteoporosis International.

No more fracture trials in osteoporosis?

I. Reid, 2020, The lancet. Diabetes & endocrinology.

Denosumab for glucocorticoid-induced osteoporosis

I. Reid, 2018, Nature Reviews Endocrinology.

Effects of Up to 5 Years of Denosumab Treatment on Bone Histology and Histomorphometry: The FREEDOM Study Extension

Jacques P. Brown, I. Reid, P. Miller, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Determinants of sex hormone‐binding globulin in normal postmenopausal women

I. Reid, R. Ames, M. Evans, 2001, Clinical endocrinology.

Effect of Hormone Replacement Therapy on Bone Mineral Density in Postmenopausal Women with Mild Primary Hyperparathyroidism

I. Reid, A. Grey, M. Evans, 1996, Annals of Internal Medicine.

Differences in overlapping meta-analyses of vitamin D supplements and falls.

I. Reid, A. Grey, M. Bolland, 2014, The Journal of clinical endocrinology and metabolism.

Clinical Aspects of the Use of Vitamin D and Its Metabolites in Osteoporosis

I. Reid, 2010 .

Effects of 25-hydroxyvitamin D level and its change on parathyroid hormone in premenopausal Chinese women

I. Reid, J. Woo, G. Gamble, 2010, Osteoporosis International.

Vitamin D sufficiency: reply to letter by Heaney

I. Reid, A. Grey, M. Bolland, 2007, Osteoporosis International.

Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.

I. Reid, G. Gamble, A. Grey, 2005, The Journal of clinical endocrinology and metabolism.

Determinants of vitamin D status in older women living in a subtropical climate

I. Reid, R. Ames, G. Gamble, 2005, Osteoporosis International.

The skeleton in pregnancy and lactation

I. Reid, 2002, Internal medicine journal.

Goal‐Directed Treatment for Osteoporosis: A Progress Report From the ASBMR‐NOF Working Group on Goal‐Directed Treatment for Osteoporosis

D. Kiel, S. Cummings, C. Cooper, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three‐year continued therapy and resolution of effect

R. Rizzoli, I. Reid, J. Eisman, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Dietary calcium intake and change in bone mineral density in older adults: a systematic review of longitudinal cohort studies

I. Reid, G. Gamble, William Leung, 2021, European Journal of Clinical Nutrition.

Dietary calcium intake and bone loss over 6 years in osteopenic postmenopausal women.

I. Reid, G. Gamble, A. Horne, 2019, The Journal of clinical endocrinology and metabolism.

The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women.

I. Reid, R. Ames, M. Evans, 1991, The Journal of clinical endocrinology and metabolism.

Relationships Between Body Fat and Bone Mass

I. Reid, 2013 .

Hormone replacement therapy causes a respiratory alkalosis in normal postmenopausal women.

I. Reid, A. Grey, M. Evans, 1999, The Journal of clinical endocrinology and metabolism.

Calcitonin in the prevention and treatment of glucocorticoid-induced osteoporosis

I. Reid, F. Wu, 2000 .

Bone density in women receiving depot medroxyprogesterone acetate for contraception.

I. Reid, R. Ames, T. Cundy, 1991, BMJ.

Stable bone density in HAART-treated individuals with HIV: a meta-analysis.

I. Reid, G. Gamble, A. Grey, 2011, The Journal of clinical endocrinology and metabolism.

Meeting report from the 17th scientific meeting of the international bone and mineral societyJune 24-29, 2007 in Montreal, Quebec, Canada

J. Aubin, I. Reid, R. Bouillon, 2007 .

Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer

I. Reid, A. Grey, M. Bolland, 2014, Annals of Internal Medicine.

Reprint: Paget's disease of bone.

I. Reid, T. Cundy, 2012, Clinical biochemistry.

Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2010, The American journal of clinical nutrition.

Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2005, The Journal of clinical endocrinology and metabolism.

I. Reid, J. Cornish, P. Baldock, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Obesity and osteoporosis.

I. Reid, 2006, Annales d'endocrinologie.

CHAPTER 41 – Steroid-Induced Osteoporosis

I. Reid, 2006 .

Glucocorticoid-induced osteoporosis.

I. Reid, 2000, Bailliere's best practice & research. Clinical endocrinology & metabolism.

Calcium and Cardiovascular Disease

I. Reid, M. Bolland, Sarah M Birstow, 2017, Endocrinology and metabolism.

Cardiovascular Complications of Calcium Supplements

I. Reid, M. Bolland, S. Bristow, 2015, Journal of cellular biochemistry.

Cardiovascular endocrinology: Calcium supplements—vascular risks versus bone benefits?

I. Reid, 2013, Nature Reviews Endocrinology.

Bone density in healthy men after cessation of calcium supplements: 20-month follow-up of a randomized controlled trial

I. Reid, R. Ames, G. Gamble, 2014, Osteoporosis International.

Re: Severe vitamin D deficiency: a prerequisite for chronic obstructive pulmonary disease responsiveness to vitamin D supplementation?

I. Reid, A. Grey, M. Bolland, 2012, Annals of internal medicine.

Errors in NOF meta-analyses of calcium and vitamin D supplements

A. Avenell, I. Reid, A. Grey, 2016, Osteoporosis International.

Should We Prescribe Calcium Supplements For Osteoporosis Prevention?

I. Reid, 2014, Journal of bone metabolism.

The acute biochemical effects of four proprietary calcium preparations.

I. Reid, H. Ibbertson, B. Schooler, 1986, Australian and New Zealand journal of medicine.

Acute effects of calcium citrate with or without a meal, calcium-fortified juice and a dairy product meal on serum calcium and phosphate: a randomised cross-over trial.

I. Reid, G. Gamble, A. Horne, 2015, The British journal of nutrition.

Calcium supplements and cardiovascular risk in the Women’s Health Initiative

I. Reid, A. Grey, M. Bolland, 2013, Osteoporosis International.

Insulin increases histomorphometric indices of bone formation In vivo

I. Reid, J. Cornish, K. Callon, 1996, Calcified Tissue International.

Stimulation of Osteoblast Proliferation by C‐Terminal Fragments of Parathyroid Hormone–Related Protein

I. Reid, J. Cornish, K. Callon, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

In vitro and in vivo effects of adiponectin on bone.

I. Reid, J. Cornish, K. Callon, 2009, Endocrinology.

Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia. Effect of successful tumor resection on mineral homeostasis.

I. Reid, S. Teitelbaum, A. Dusso, 1987, The American journal of medicine.

Resistin, an adipocytokine, stimulates osteoblast and osteoclast proliferation

I. Reid, J. Cornish, K. Callon, 2006 .

Skeletal phenotype of the leptin receptor–deficient db/db mouse

I. Reid, J. Cornish, K. Callon, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of Vitamin D Supplementation on Strength, Physical Performance, and Falls in Older Persons: A Systematic Review

I. Reid, N. Latham, Craig S. Anderson, 2003, Journal of the American Geriatrics Society.

Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial

I. Reid, C. McGhee, D. Patel, 2015, Osteoporosis International.

Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention

A. Avenell, I. Reid, A. Grey, 2017, Osteoporosis International.

Zoledronate Slows Weight Loss and Maintains Fat Mass in Osteopenic Older Women: Secondary Analysis of a Randomized Controlled Trial

I. Reid, G. Gamble, A. Horne, 2020, Calcified Tissue International.

Effects of Leptin on the Skeleton.

I. Reid, J. Cornish, P. Baldock, 2018, Endocrine reviews.

Direct Actions of Leptin on Bone Remodeling

I. Reid, J. Comish, 2004, Calcified Tissue International.

Glucocorticoid osteoporosis--mechanisms and management.

I. Reid, 1997, European journal of endocrinology.

TWO-YEAR FOLLOW-UP OF BIPHOSPHONATE (APD) TREATMENT IN STEROID OSTEOPOROSIS

I. Reid, H. Ibbertson, A. King, 1988, The Lancet.

Bisphosphonates in pregnancy and lactation-associated osteoporosis

I. Reid, A. Grey, R. Singh, 2006, Osteoporosis International.

Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice.

I. Reid, J. Cornish, K. Callon, 1995, Biochemical and biophysical research communications.

X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry.

W. Murphy, I. Reid, S. Teitelbaum, 1991, The American journal of medicine.

Lactoferrin and bone; structure-activity relationships.

I. Reid, J. Cornish, K. Callon, 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Ghrelin is an Osteoblast Mitogen and Increases Osteoclastic Bone Resorption In Vitro

I. Reid, J. Cornish, K. Callon, 2011, International journal of peptides.

Relationships between fat and bone

I. Reid, 2008, Osteoporosis International.

Bisphosphonate Therapy for Secondary Osteoporosis: Adult Perspective

I. Reid, 2011, Hormone Research in Paediatrics.

Adipose Tissue and Bone

I. Reid, 2009 .

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial.

I. Reid, G. Gamble, A. Grey, 2007, The Journal of clinical endocrinology and metabolism.

Determinants of vitamin D status in older men living in a subtropical climate

I. Reid, R. Ames, G. Gamble, 2006, Osteoporosis International.

Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development.

I. Reid, J. Cornish, K. Callon, 2001, Bone.

Regular exercise dissociates fat mass and bone density in premenopausal women.

I. Reid, A. Grey, M. Legge, 1995, The Journal of clinical endocrinology and metabolism.

Parathyroid hormone depresses cytosolic pH and DNA synthesis in osteoblast-like cells.

I. Reid, K. Hruska, L. Avioli, 1988, The American journal of physiology.

Amylin and Calcitonin Gene-Related Peptide

I. Reid, J. Cornish, D. Naot, 2008 .

Chapter 36 – Amylin and Calcitonin Gene-Related Peptide

I. Reid, J. Cornish, 2002 .

The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women

I. Reid, R. Ames, G. Gamble, 2007, Osteoporosis International.

Comment on Kanis et al.: Pitfalls in the external validation of FRAX

I. Reid, G. Gamble, A. Grey, 2012, Osteoporosis International.

Pharmacotherapy of Paget's disease of bone

I. Reid, 2012, Expert opinion on pharmacotherapy.

Glucocorticoids and Osteoporosis

I. Reid, 1999 .

REVIEW ARTICLE G lucocorticoid 0s teoporosis

I. Reid, A. Veale, 1994 .

Time to end steroid-induced fractures.

I. Reid, 2001, Archives of dermatology.

Regulation of osteoblast proliferation by leukemia inhibitory factor

I. Reid, J. Cornish, K. Callon, 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients

I. Reid, A. Rodgers, S. MacMahon, 2000, Acta orthopaedica Scandinavica.

Accelerated bone loss in post‐menopausal women with mild primary hyperparathyroidism

I. Reid, A. Grey, M. Evans, 1996, Clinical endocrinology.

Relationships among body mass, its components, and bone 1 1 Published simultaneously at BoneKEy-Oste

I. Reid, 2002 .

Post‐pregnancy osteoporosis associated with hypercalcaemia

I. Reid, M. Evans, D. Wattie, 1992, Clinical endocrinology.

Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo.

G. Churchill, I. Reid, K. Shockley, 2007, Endocrinology.

Association of fat-free mass and training status with left ventricular size and mass in endurance-trained athletes.

R. Doughty, I. Reid, H. Oxenham, 2004, Journal of the American College of Cardiology.

Path Analysis Identifies Receptor Activator of Nuclear Factor-κB Ligand, Osteoprotegerin, and Sclerostin as Potential Mediators of the Tophus-bone Erosion Relationship in Gout

I. Reid, G. Gamble, J. Cornish, 2016, The Journal of Rheumatology.

Erosion Relationship in Gout Osteoprotegerin , and Sclerostin as Potential Mediators of the Tophus-bone B Ligand , κ Path Analysis Identifies Receptor Activator of Nuclear Factor-Dalbeth

I. Reid, G. Gamble, J. Cornish, 2015 .

Bone mineral density is not reduced in HIV‐infected Caucasian men treated with highly active antiretroviral therapy

I. Reid, G. Gamble, A. Grey, 2006, Clinical endocrinology.

Training and Left Ventricular Mass ssociation of Fat-Free Mass and raining Status With Left Ventricular ize and Mass in Endurance-Trained Athletes

R. Doughty, I. Reid, G. Gamble, 2016 .

mass in endurance-trained athletes Association of fat-free mass and training status with left ventricular size and

R. Doughty, I. Reid, H. Oxenham, 2011 .

Randomised controlled trial of vitamin D supplementation in sarcoidosis

I. Reid, G. Gamble, A. Grey, 2013, BMJ Open.

Vitamin D Deficiency and Its Health Consequences in New Zealand

I. Reid, M. Bolland, 2010 .

The effects of seasonal variation of 25-hydroxyvitamin D on diagnosis of vitamin D insufficiency.

I. Reid, G. Gamble, A. Grey, 2008, The New Zealand medical journal.

Bone mineral content in Polynesian and white New Zealand women.

I. Reid, H. Ibbertson, M. Mackie, 1986, British medical journal.

Vitamin D deficiency and tuberculosis

I. Reid, 2000, The Lancet.

25‐Hydroxyvitamin D Threshold for the Effects of Vitamin D Supplements on Bone Density: Secondary Analysis of a Randomized Controlled Trial

I. Reid, G. Gamble, J. Tang, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effect of monthly high‐dose vitamin D on bone density in community‐dwelling older adults substudy of a randomized controlled trial

C. Camargo, I. Reid, C. Camargo, 2017, Journal of internal medicine.

Glucocorticoid-induced osteoporosis: assessment and treatment.

I. Reid, 1998, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Bisphosphonates for Prevention of Bone Loss in Glucocorticoid-Treated Young People

I. Reid, 2019, EClinicalMedicine.

X‐Linked Hypophosphatemia: A Clinical, Biochemical, and Histopathologic Assessment of Morbidity in Adults

W. A. Murphy, I. Reid, S. Teitelbaum, 1989, Medicine.

Characteristics of children with florid vitamin D deficient rickets in the Auckland region in 1998.

I. Reid, C. Grant, A. McNeil, 2000, The New Zealand medical journal.

A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

Jacques P. Brown, I. Reid, P. Miller, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

Jacques P. Brown, I. Reid, P. Miller, 2005, The New England journal of medicine.

INSULIN‐LIKE GROWTH FACTOR 1 AND BONE TURNOVER IN GLUCOCORTICOID‐TREATED AND CONTROL SUBJECTS

P. Gluckman, I. Reid, H. Ibbertson, 1989, Clinical endocrinology.

Absence of somatic SQSTM1 mutations in Paget's disease of bone.

I. Reid, J. Cornish, K. Callon, 2009, The Journal of clinical endocrinology and metabolism.

Pathogenesis and management of Paget's disease of bone

I. Reid, A. Langston, S. Ralston, 2008, The Lancet.

Normal bone mineral density following cure of Cushing's syndrome

I. Reid, P. Manning, M. Evans, 1992, Clinical endocrinology.

Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's disease.

I. Reid, J. Cornish, K. Callon, 2008, The Journal of clinical endocrinology and metabolism.

Clinical effects of vitamin D supplementation

I. Reid, 2014 .

Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone.

I. Reid, G. Gamble, T. Cundy, 2004, Bone.

Skeletal actions of fasting-induced adipose factor (FIAF).

I. Reid, J. Cornish, M. Watson, 2013, Endocrinology.

Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells.

I. Reid, J. Cornish, K. Callon, 2011, Bone.

Short-term effects of high dose oral medroxyprogesterone acetate on bone density in premenopausal women.

I. Reid, C. Farquhar, J. Cornish, 1996, The Journal of clinical endocrinology and metabolism.

Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells.

I. Reid, J. Cornish, K. Callon, 2008, Arthritis and rheumatism.

Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.

I. Reid, A. Grey, M. Evans, 1996, Annals of internal medicine.

The effect of age on the microarchitecture and profile of gene expression in femoral head and neck bone from patients with osteoarthritis

Jacob T. Munro, I. Reid, G. Gamble, 2020, Bone reports.

Testosterone therapy in glucocorticoid-treated men

I. Reid, M. Evans, J. Stapleton, 2006, Osteoporosis International.

Calcium Intake and Cardiovascular Disease Risk

A. Avenell, I. Reid, A. Grey, 2017, Annals of Internal Medicine.

Hip fracture incidence among older people in Auckland: a population-based study.

I. Reid, R. Norton, A. J. Campbell, 1995, The New Zealand medical journal.

Poster 150: Effect of Once-Yearly Infusion of 5mg of Zoledronic Acid in Postmenopausal Women With Osteoporosis: The HORIZON-Pivotal Fracture Trial

S. Cummings, I. Reid, R. Eastell, 2007 .

Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial

I. Reid, G. Gamble, J. Cornish, 2010, Annals of the rheumatic diseases.

Increased abdominal fat in young women of Indian origin.

I. Reid, T. Cundy, M. Evans, 2005, Asia Pacific journal of clinical nutrition.

Original Article

I. Reid, T. Cundy, M. Evans, 1999 .

A novel combination of ibuprofen and codeine phosphate in the treatment of osteoarthritis: A double-blind placebo controlled study

I. Reid, A. Miller, J. Hosie, 1992 .

Serum blocks the osteolytic effect of cortisol in neonatal mouse calvaria

I. Reid, D. Gray, C. Lowe, 1990, Calcified Tissue International.

Residential status and risk of hip fracture.

I. Reid, R. Norton, A. J. Campbell, 1999, Age and ageing.

Relationship Between Pretreatment Rate of Bone Loss and Bone Density Response to Once‐Yearly ZOL: HORIZON‐PFT Extension Study

S. Cummings, S. Boonen, I. Reid, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evidence for a Major Gene for Bone Mineral Density in Idiopathic Osteoporotic Families

R. M. Edwards, L. Cardon, I. Reid, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of Hormone Replacement Therapy on Bone Mineral Density in Postmenopausal Women With Primary Hyperparathyroidism

I. Reid, A. Grey, M. Evans, 2016 .

Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.

I. Reid, A. Grey, M. Evans, 2000, Archives of internal medicine.

Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up

I. Reid, A. Horne, B. Mihov, 2019, Calcified Tissue International.

Bone Loss After Denosumab: Only Partial Protection with Zoledronate

I. Reid, G. Gamble, A. Horne, 2017, Calcified Tissue International.

Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region.

C. Cooper, I. Reid, A. Mithal, 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

The effect of leukemia inhibitory factor on bone in vivo.

I. Reid, S. Edgar, J. Cornish, 1993, Endocrinology.

Parathyroid hormone acutely elevates intracellular calcium in osteoblastlike cells.

I. Reid, K. Hruska, L. Avioli, 1987, The American journal of physiology.

Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.

I. Reid, G. Gamble, A. Grey, 2008, The New Zealand medical journal.

The chronic and severe forms of eosinophilic meningitis.

I. Reid, W. Wallis, 1984, Australian and New Zealand journal of medicine.

Benefits of Bisphosphonate Therapy: Beyond the Skeleton

I. Reid, E. Billington, 2020, Current Osteoporosis Reports.

Testosterone Levels Following Decreases in Serum Osteocalcin

I. Reid, A. Grey, M. Bolland, 2013, Calcified Tissue International.

Bone mineral density remains stable in HAART‐treated HIV‐infected men over 2 years

I. Reid, G. Gamble, A. Grey, 2007, Clinical endocrinology.

Leptin deficiency--lessons in regional differences in the regulation of bone mass.

I. Reid, 2004, Bone.

Bisphosphonates in Paget's disease.

I. Reid, D. Hosking, 2011, Bone.

Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease

I. Reid, J. Adachi, P. Miller, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates

I. Reid, A. Horne, B. Mihov, 2018, Calcified Tissue International.

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

I. Reid, H. Ibbertson, A. King, 1988 .

New insights into ONJ

I. Reid, 2013 .

Parathyroid hormone-related protein-(107-139) inhibits bone resorption in vivo.

I. Reid, J. Cornish, K. Callon, 1997, Endocrinology.

Once-yearly zoledronate—an effective preventative therapy for new fractures after hip fracture?

I. Reid, 2008, Nature Clinical Practice Endocrinology &Metabolism.

A prediction tool for vitamin D deficiency in New Zealand adults

C. Camargo, I. Reid, K. Khaw, 2020, Archives of Osteoporosis.

Novel Bone-Forming Agents

I. Reid, 1998 .

The roles of calcium and vitamin D in the prevention of osteoporosis.

I. Reid, 1998, Endocrinology and metabolism clinics of North America.

Vitamin D Supplements and the Risk of Falls.

I. Reid, A. Grey, M. Bolland, 2015, JAMA internal medicine.

Prevention of glucocorticoid‐induced osteoporosis

I. Reid, A. Stewart, Beth Schooler, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Screening for Vitamin D Deficiency

I. Reid, A. Grey, M. Bolland, 2015, Annals of Internal Medicine.

Ten years of very infrequent zoledronate therapy in older women: an open-label extension of a randomized trial.

I. Reid, G. Gamble, A. Grey, 2020, The Journal of clinical endocrinology and metabolism.

Clinical Limitation of Bone-Specific Alkaline Phosphatase Assays

I. Reid, B. Orr-Walker, F. Wu, 2001, Annals of clinical biochemistry.

Recommendations from the vitamin D and calcium forum

I. Reid, J. Eisman, P. Sambrook, 2005 .

High‐dose vitamin D: Without benefit but not without risk

I. Reid, 2018, Journal of internal medicine.

Reply to RT Chlebowski et al

I. Reid, G. Gamble, A. Grey, 2012 .

Calcium and vitamin D do not prevent fractures in community-dwelling adults

I. Reid, 2018, BMJ Evidence-Based Medicine.

Vitamin D supplements do not prevent falls

I. Reid, A. Grey, M. Bolland, 2016, British Medical Journal.

Calcium Supplements Increase Risk of Myocardial Infarction

A. Avenell, I. Reid, A. Grey, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Authors' reply.

I. Reid, G. Gamble, A. Grey, 2014, The Lancet Diabetes and Endocrinology.

Vitamin D supplements do not reduce mortality risk

I. Reid, A. Grey, M. Bolland, 2014, BMJ : British Medical Journal.

Vitamin D supplements and bone mineral density – Authors' reply

I. Reid, A. Grey, M. Bolland, 2014, The Lancet.

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis

A. Avenell, I. Reid, G. Gamble, 2011, BMJ : British Medical Journal.

Calcium fortified foods or supplements for older people?

I. Reid, S. Bristow, 2016, Maturitas.

Decade in review—bone: Great strides made but still further to go

I. Reid, 2015, Nature Reviews Endocrinology.

Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women

I. Reid, G. Gamble, A. Horne, 2015, British Journal of Nutrition.

What is the appropriate MHRA regulatory response to calcium’s increased cardiovascular risk?

A. Avenell, I. Reid, A. Grey, 2013, BMJ.

An inappropriate response?

I. Reid, A. Grey, M. Bolland, 2013, BMJ : British Medical Journal.

Misclassification does not explain increased cardiovascular risks of calcium supplements

I. Reid, A. Grey, M. Bolland, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Calcium supplements and risk of myocardial infarction: an hypothesis twice tested.

I. Reid, A. Grey, M. Bolland, 2012, The American journal of medicine.

Calcium supplements and cardiovascular risk

I. Reid, A. Grey, M. Bolland, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Stable bone mineral density over 6 years in HIV‐infected men treated with highly active antiretroviral therapy (HAART)

I. Reid, G. Gamble, A. Grey, 2012, Clinical endocrinology.

Editorial: Glucocorticoid Effects on Bone

I. Reid, 1998 .

Effects of amylin and adrenomedullin on the skeleton.

I. Reid, J. Cornish, Reid Ir, 2001, Journal of musculoskeletal & neuronal interactions.

Dissociation of the effects of amylin on osteoblast proliferation and bone resorption.

I. Reid, J. Cornish, K. Callon, 1998, The American journal of physiology.

Dissociation of the effects of amylin on osteoblast proliferation and bone resorption.

I. Reid, J. Cornish, K. Callon, 1998, American journal of physiology. Endocrinology and metabolism.

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial.

I. Reid, G. Gamble, A. Grey, 2007, The Journal of clinical endocrinology and metabolism.

Plasma testosterone concentrations in asthmatic men treated with glucocorticoids.

I. Reid, J. France, J. Pybus, 1985, British medical journal.

Effects of leukemia inhibitory factor on bone resorption and DNA synthesis in neonatal mouse calvaria

I. Reid, T. Martin, J. Cornish, 1991, Calcified Tissue International.

Leukaemia inhibitory factor and bone cell function.

I. Reid, T. Martin, R. Evely, 1992, Ciba Foundation symposium.

Calcitropic hormone levels in polynesians: evidence against their role in interracial differences in bone mass.

I. Reid, M. Evans, B. Schooler, 1990, The Journal of clinical endocrinology and metabolism.

Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.

I. Reid, G. Gamble, A. Grey, 2011, The American journal of clinical nutrition.

Calcium supplementation and cancer incidence.

I. Reid, M. Bolland, 2008, The American journal of clinical nutrition.

Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics.

I. Reid, H. Ibbertson, 1987, Hormone research.

Osteonecrosis of the jaw

I. Reid, T. Cundy, 2008, Skeletal Radiology.

Effects of vertical‐banded gastroplasty on bone and mineral metabolism in obese patients

I. Reid, T. Cundy, M. Evans, 1996, The British journal of surgery.

Benefits, Risks and Costs of Calcium Supplementation in Postmenopausal Women

I. Reid, 2012, PharmacoEconomics.

Characterization of phospholipase C activity of the plasma membrane and cytosol of an osteoblast-like cell line.

I. Reid, K. Hruska, L. Avioli, 1989, The American journal of the medical sciences.

Transient hypercalcemia following overdoses of soluble aspirin tablets.

I. Reid, 1985, Australian and New Zealand journal of medicine.

Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

P. Barber, R. Doughty, I. Reid, 2008, BMJ : British Medical Journal.

Investigating harms in clinical trials – no easy task

I. Reid, G. Gamble, A. Grey, 2010, International journal of clinical practice.

“Cherry picking” did not occur in studied example

I. Reid, A. Grey, M. Bolland, 2010, BMJ : British Medical Journal.

Effect of calcium supplementation on hip fractures: reply to correspondence

I. Reid, A. Grey, M. Bolland, 2009, Osteoporosis International.

Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) by Rosiglitazone Suppresses Components of the Insulin-Like Growth Factor Regulatory System in Vitro and in Vivo

G. Churchill, I. Reid, K. Shockley, 2007 .

WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk

David M. Evans, T. Spector, T. Lehtimäki, 2012, PLoS genetics.

Recovery of bone density in women who stop using medroxyprogesterone acetate

I. Reid, J. Cornish, T. Cundy, 1994, BMJ.

Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget’s Disease of Bone

I. Reid, K. Maslowski, 2017, Calcified Tissue International.

Are more trials of calcium supplements really needed?

I. Reid, A. Grey, M. Bolland, 2017, Osteoporosis International.

Effects of calcium supplementation on bone and other end-points in normal older women – The Auckland Calcium Study

I. Reid, 2007 .

Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial.

I. Reid, G. Gamble, A. Grey, 2007, The Journal of clinical endocrinology and metabolism.

Zoledronate Reduces Height Loss Independently of Vertebral Fracture Occurrence in a Randomized Trial in Osteopenic Older Women

I. Reid, M. Bolland, A. Horne, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Anti‐fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial

I. Reid, G. Gamble, M. Bolland, 2019, Journal of internal medicine.

Pathogenesis of osteonecrosis of the jaw

I. Reid, 2008 .

Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial

I. Reid, G. Gamble, W. C. O'Neill, 2016, Osteoporosis International.

Osteomalacia after pamidronate for Paget's disease

I. Reid, T. Cundy, H. Ibbertson, 1994, The Lancet.

Effects of elevated serum urate on cardiometabolic and kidney function markers in a randomised clinical trial of inosine supplementation

T. Merriman, I. Reid, D. Mount, 2022, Scientific reports.

The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post‐menopausal women

I. Reid, R. Ames, T. Cundy, 1998, Clinical endocrinology.

The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells.

I. Reid, J. Cornish, K. Callon, 2004, Molecular endocrinology.

Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 1995, The American journal of medicine.

Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial

I. Reid, G. Gamble, N. Dalbeth, 2014, Annals of the rheumatic diseases.

Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo.

I. Reid, J. Cornish, K. Callon, 2002, The Journal of endocrinology.

Leukemia inhibitory factor is mitogenic to osteoblasts.

I. Reid, S. Edgar, J. Cornish, 1997, Bone.

A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery

L Dunn, I. Reid, A. Rodgers, 2000, Acta orthopaedica Scandinavica.

Postmenopausal osteoporosis

S. Cummings, D. Gold, I. Reid, 2016, Nature Reviews Disease Primers.

Osteonecrosis of the jaw: who gets it, and why?

I. Reid, 2009, Bone.

Sources of interracial variation in bone mineral density

I. Reid, J. Cornish, T. Cundy, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Lactoferrin Is a Potent Regulator of Bone Cell Activity and Increases Bone Formation in Vivo

Edward N Baker, Jillian Cornish, Dorit Naot, 2022 .

The assessment of intestinal calcium absorption using stable strontium

I. Reid, J. Pybus, T. Lim, 1986, Calcified Tissue International.

Does degree of baldness influence vitamin D status?

I. Reid, R. Ames, A. Grey, 2008, The Medical journal of Australia.

Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis.

I. Reid, G. Gamble, A. Grey, 2010, The Journal of clinical endocrinology and metabolism.

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

A. Avenell, I. Reid, J. Baron, 2010, BMJ : British Medical Journal.

Premature hair graying and bone mineral density.

I. Reid, R. Ames, M. Evans, 1997, The Journal of clinical endocrinology and metabolism.

Cytoplasmic pH regulation in canine renal proximal tubule cells.

I. Reid, K. Hruska, L. Avioli, 1987, Kidney international.

Pathogenesis of Osteoporosis

I. Reid, E. Billington, 2019, Encyclopedia of Endocrine Diseases.

An in vivo model for the rapid assessment of the local effects of parathyroid hormone on bone histomorphometry.

I. Reid, J. Cornish, K. Callon, 1995, Bone.

Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes.

I. Reid, J. Cornish, K. Callon, 1999, American journal of physiology. Endocrinology and metabolism.

Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes.

I. Reid, J. Cornish, K. Callon, 1999, The American journal of physiology.

Skeletal health in adults with HIV infection.

I. Reid, A. Grey, M. Bolland, 2015, The lancet. Diabetes & endocrinology.

CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis.

I. Reid, G. Gamble, A. Grey, 2007, The Journal of clinical endocrinology and metabolism.

Title: Low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis Running title: HIV, body weight and BMD Authors:

I. Reid, G. Gamble, A. Grey, 2007 .

Lactoferrin--a novel bone growth factor.

Andrew Grey, Jillian Cornish, Dorit Naot, 2005, Clinical medicine & research.

Meeting report from the 25th annual meeting of the American society for bone and mineral research

I. Reid, G. Karsenty, R. Faccio, 2003 .

Molecular characterisation of osteoblasts from bone obtained from people of Polynesian and European ancestry undergoing joint replacement surgery

I. Reid, G. Gamble, J. Cornish, 2021, Scientific Reports.

Spinal bone density in women using depot medroxyprogesterone contraception

I. Reid, J. Cornish, T. Cundy, 1998, Osteoporosis International.

A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.

I. Reid, R. Ames, G. Gamble, 2003, The Journal of clinical endocrinology and metabolism.

Fat and bone.

I. Reid, 2010, Archives of biochemistry and biophysics.

Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long‐term continuation on bone turnover and fracture risk—a perspective

S. Boonen, I. Reid, P. Sambrook, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effect of sub-elite competitive running on bone density, body composition and sexual maturity of adolescent females

I. Reid, G. Gamble, M. Evans, 2003, Osteoporosis International.

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

S. Cummings, S. Boonen, J. Cauley, 2007, The New England journal of medicine.

Leukemia Inhibitory Factor: A Novel Bone-Active Cytokine*

I. Reid, T. Martin, D. Hilton, 1990 .

The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase.

I. Reid, J. Cornish, K. Callon, 2002, Endocrinology.

Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases.

I. Reid, J. Cornish, K. Callon, 2001, Endocrinology.

Actions of fibroblast growth factor-8 in bone cells in vitro.

I. Reid, J. Cornish, K. Callon, 2009, American journal of physiology. Endocrinology and metabolism.

Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis.

I. Reid, E. Wallace, J. Wong, 1995, Archives of internal medicine.

Role of vitamin D deficiency in cardiovascular disease

Mark J Bolland, I. Reid, M. Bolland, 2012, Heart.

Targeting Sclerostin in Postmenopausal Osteoporosis: Focus on Romosozumab and Blosozumab

I. Reid, 2017, BioDrugs.

Effects of Zoledronate on Cancer, Cardiac Events, and Mortality in Osteopenic Older Women

I. Reid, G. Gamble, A. Horne, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.

D. Kiel, M. Sabatine, J. Reginster, 2019, The lancet. Diabetes & endocrinology.

Fracture Prevention with Zoledronate in Older Women with Osteopenia

I. Reid, G. Gamble, M. Bolland, 2018, The New England journal of medicine.

Short-term and long-term effects of osteoporosis therapies

I. Reid, 2015, Nature Reviews Endocrinology.

Hypercalcemia and squamous cell carcinoma complicating chronic osteomyelitis.

I. Reid, A. King, A. Fenton, 1989, Australian and New Zealand journal of medicine.

A broader strategy for osteoporosis interventions

I. Reid, 2020, Nature Reviews Endocrinology.

Effect of pravastatin on frequency of fracture in the LIPID study: secondly analysis of a randomised controlled trial

I. Reid, A. Tonkin, J. Emberson, 2001, The Lancet.

Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium.

D. Kiel, A. Hofman, A. Uitterlinden, 2014, Human molecular genetics.

Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study

I. Reid, W. Taylor, N. Dalbeth, 2011, Annals of the rheumatic diseases.

Effect of oral zoledronate administration on bone turnover in older women

I. Reid, Mengyang Liu, Jingyuan Wen, 2022, British journal of clinical pharmacology.

Systemic administration of a novel octapeptide, amylin-(1---8), increases bone volume in male mice.

I. Reid, J. Cornish, K. Callon, 2000, American journal of physiology. Endocrinology and metabolism.

Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice.

I. Reid, J. Cornish, K. Callon, 1998, American journal of physiology. Endocrinology and metabolism.

Adenylate cyclase blockers dissociate PTH-stimulated bone resorption from cAMP production.

I. Reid, J. Cornish, S. Skinner, 1990, The American journal of physiology.

Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging

I. Reid, J. Wilson, I. Holdaway, 2003, Internal medicine journal.

Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis

Harry K. Genant, Paul D. Miller, Bess Dawson-Hughes, 1999, Osteoporosis International.

Vitamin D supplementation and falls: a trial sequential meta-analysis.

I. Reid, G. Gamble, A. Grey, 2014, The lancet. Diabetes & endocrinology.

The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT)

S. Cummings, S. Boonen, J. Cauley, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

S. Cummings, C. Christiansen, I. Reid, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Paget's disease of bone: an endocrine society clinical practice guideline.

I. Reid, M. Murad, E. Siris, 2014, The Journal of clinical endocrinology and metabolism.

Management of Paget’s disease of bone

I. Reid, 2019, Osteoporosis International.

Response to letter by Ralston et al.

I. Reid, E. Siris, D. Hosking, 2015, Journal of Clinical Endocrinology and Metabolism.

Treatment of Paget’s Disease of Bone

I. Reid, 2016 .

A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype.

I. Reid, M. Hegde, J. Mulley, 2002, Human molecular genetics.

Reply to Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide

I. Reid, K. Saag, J. Curtis, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Emerging and potential therapies for osteoporosis

I. Reid, A. Grey, 2005, Expert opinion on investigational drugs.

Paget's disease of bone.

I. Reid, T. Cundy, 2012, Clinical biochemistry.

Durability of Response to Zoledronate Treatment and Competing Mortality in Paget's Disease of Bone

I. Reid, A. Grey, T. Cundy, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Long-Term Effects of Intravenous Ibandronate in Paget’s Disease of Bone

I. Reid, G. Gamble, T. Cundy, 2017, Calcified Tissue International.

Treatment of Paget’s Disease of Bone with Denosumab: Case Report and Literature Review

I. Reid, Sonakshi Sharma, R. Kalluru, 2016, Calcified Tissue International.

Re-treatment of relapsed Paget's disease of bone with zoledronic acid: results from an open-label study.

Jacques P. Brown, I. Reid, N. Levitt, 2013, BoneKEy reports.

Long‐Term Control of Bone Turnover in Paget's Disease With Zoledronic Acid and Risedronate

Jacques P. Brown, I. Reid, P. Miller, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features.

W. Murphy, I. Reid, B. Siegel, 1989, Radiology.

Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspective.

I. Reid, A. Grey, T. Cundy, 2006, The New Zealand medical journal.

The incidence of acute anterior uveitis after intravenous zoledronate.

I. Reid, C. McGhee, D. Patel, 2013, Ophthalmology.

Characterization of and risk factors for the acute-phase response after zoledronic acid.

I. Reid, D. Black, G. Gamble, 2010, The Journal of clinical endocrinology and metabolism.

Differential Gene Expression in Cultured Osteoblasts and Bone Marrow Stromal Cells From Patients With Paget's Disease of Bone

I. Reid, Sarah Song, J. Cornish, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Zoledronate: Efficacy and Safety

I. Reid, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD)

I. Reid, H. Ibbertson, A. King, 1988, The Lancet.

The Effects of Re-challenge in Patients with a History of Acute Anterior Uveitis Following Intravenous Zoledronate

I. Reid, C. McGhee, D. Patel, 2015, Calcified Tissue International.

Bone density is normal and does not change over 2 years in sarcoidosis

I. Reid, G. Gamble, A. Grey, 2015, Osteoporosis International.

Adipokine Effects on Bone

I. Reid, J. Richards, J. B. Richards, 2009 .

Bone Mineral Density in Patients with Treated Addison’s Disease

I. Reid, M. Evans, G. Braatvedt, 1999, Osteoporosis International.

International Consensus on Diagnosis and Management of Osteonecrosis of the Jaw

C. Cooper, D. Felsenberg, I. Reid, 2013 .

The effect of calcium supplementation on serum urate: analysis of a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2008, Rheumatology.

Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial

I. Reid, R. Ames, G. Gamble, 2012, Annals of the rheumatic diseases.

Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis

I. Reid, B. Arroll, S. Ogston, 2003, BMJ : British Medical Journal.

Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women’s Health Initiative Limited-Access Dataset

I. Reid, G. Gamble, A. Grey, 2015, PloS one.

Efficacy and Tolerability of Tricyclic Antidepressants and SSRIs Compared With Placebo for Treatment of Depression in Primary Care: A Meta-Analysis

I. Reid, B. Arroll, S. Ogston, 2005, The Annals of Family Medicine.

Is physical activity protective against hip fracture in frail older people?

I. Reid, R. Norton, A. J. Campbell, 2001, Age and ageing.

Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis

I. Reid, A. Grey, M. Bolland, 2014, The Lancet.

Depression: current approaches to management in primary care

I. Reid, I. Cameron, 2009 .

A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.

I. Reid, R. Eastell, N. Watts, 2004, Archives of internal medicine.

Evaluation of the FRAX and Garvan fracture risk calculators in older women

Mark J Bolland, I. Reid, R. Ames, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial.

I. Reid, G. Gamble, A. Grey, 2014, European journal of endocrinology.

Serum testosterone levels during chronic glucocorticoid therapy.

I. Reid, 1987, Annals of internal medicine.

Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures.

I. Reid, R. Ames, G. Gamble, 2002, Archives of internal medicine.

Controversies in medicine: the role of calcium and vitamin D supplements in adults

I. Reid, M. Bolland, 2019, The Medical journal of Australia.

Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues?

I. Reid, M. Bolland, 2014, Osteoporosis International.

Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis

I. Reid, A. Grey, M. Bolland, 2014, The Lancet.

Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies

Jacques P. Brown, I. Reid, J. S. San Martin, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Do Calcium Supplements Lead to an Increase in Coronary Calcification

I. Reid, R. Ames, G. Gamble, 2009 .

Glucocorticoid Osteoporosis

I. Reid, 1999, The Journal of asthma : official journal of the Association for the Care of Asthma.

Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?

S. Cummings, S. Boonen, J. Cauley, 2014, The Journal of clinical endocrinology and metabolism.

Goal‐directed treatment of osteoporosis

S. Cummings, I. Reid, R. Eastell, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

S. Cummings, C. Christiansen, E. Vittinghoff, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency.

I. Reid, R. Ames, G. Gamble, 2007, The American journal of clinical nutrition.

PTH elevates inositol polyphosphates and diacylglycerol in a rat osteoblast-like cell line.

I. Reid, K. Hruska, L. Avioli, 1988, The American journal of physiology.

Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once‐yearly zoledronic acid 5 mg: The HORIZON‐Pivotal Fracture Trial (PFT)

S. Boonen, D. Bauer, I. Reid, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Authors’ reply

A. Avenell, I. Reid, G. Gamble, 2011, BMJ : British Medical Journal.

Calcium supplements and cardiovascular risk: 5 years on

I. Reid, A. Grey, M. Bolland, 2013, Therapeutic advances in drug safety.

Asia-pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures.

I. Reid, A. Mithal, K. Tsai, 2023, Journal of the Formosan Medical Association = Taiwan yi zhi.

The Interaction of Acute‐Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial

J. Cauley, I. Reid, Toshitaka Nakamura, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Duration of Antiresorptive Effects of Low‐Dose Zoledronate in Osteopenic Postmenopausal Women: A Randomized, Placebo‐Controlled Trial

I. Reid, G. Gamble, A. Grey, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON‐PFT, and FREEDOM trials

S. Cummings, E. Vittinghoff, D. Bauer, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effect of osteoporosis treatment on mortality: a meta-analysis.

I. Reid, G. Gamble, A. Grey, 2010, The Journal of clinical endocrinology and metabolism.

Calcium and bone health: position statement for the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia

I. Reid, A. Devine, C. Nowson, 2009, The Medical journal of Australia.

Reasons for discrepancies in hip fracture risk estimates using FRAX and Garvan calculators.

I. Reid, G. Gamble, E. Billington, 2016, Maturitas.

Volumetric bone density of the lumbar spine is related to fat mass but not lean mass in normal postmenopausal women

I. Reid, R. Ames, M. Evans, 1994, Osteoporosis International.

Maintaining the Trust of Physicians and the Public in the Medical Literature: Report of a Task Force on Scientific Publishing of Clinical Trials

M. Drezner, I. Reid, J. Eisman, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone-Bound Bisphosphonates Inhibit Proliferation of Breast Cancer Cells

I. Reid, J. Cornish, U. Bava, 2019, Calcified Tissue International.

Body Weight and Bone Mineral Density in Hyperparathyroidism

I. Reid, A. Grey, 1995, Annals of Internal Medicine.

Evaluation and treatment of primary hyperparathyroidism.

I. Reid, A. Grey, M. Bolland, 2005, JAMA.

Intervals Between Bone Density Testing

I. Reid, G. Gamble, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

alpha -melanocyte-stimulating hormone is a novel regulator of bone.

I. Reid, J. Cornish, K. Callon, 2003, American journal of physiology. Endocrinology and metabolism.

Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.

I. Reid, P. Delmas, P. Mesenbrink, 2008, Journal of the American Dental Association.

Recent advances in understanding and managing Paget’s disease

I. Reid, 2019, F1000Research.

Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2007, The Journal of clinical endocrinology and metabolism.

Fibroblast growth factor 23 levels decline following sleeve gastrectomy

I. Reid, G. Gamble, K. Callon, 2019, Clinical endocrinology.

Government funding of health research in New Zealand.

I. Reid, P. Joyce, P. Crampton, 2014, The New Zealand medical journal.

Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial

I. Reid, G. Gamble, A. Horne, 2017, Osteoporosis International.

The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women.

I. Reid, G. Gamble, A. Grey, 2009, The Journal of clinical endocrinology and metabolism.

Has improved nutrition contributed to the hip fracture epidemic?

I. Reid, 1996, Molecular and Cellular Endocrinology.

Relation between increase in length of hip axis in older women between 1950s and 1990s and increase in age specific rates of hip fracture

I. Reid, M. Evans, K. Chin, 1994, BMJ.

Time for a moratorium on vitamin D meta-analyses?

I. Reid, A. Grey, M. Bolland, 2009, BMJ : British Medical Journal.

Steroid osteoporosis

I. Reid, 2007, Calcified Tissue International.

Predictors of Fracture in Older Women With Osteopenic Hip Bone Mineral Density Treated With Zoledronate

I. Reid, G. Gamble, M. Bolland, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Longer femoral necks in the young: a predictor of further increases in hip fracture incidence?

I. Reid, T. Cundy, M. Evans, 1996, The New Zealand medical journal.

Dietary calcium intake and rate of bone loss in men

I. Reid, G. Gamble, A. Horne, 2017, British Journal of Nutrition.

Response to publication of PRISM trial

I. Reid, A. Grey, T. Cundy, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Low-dose fluoride in postmenopausal women: a randomized controlled trial.

I. Reid, G. Gamble, K. Callon, 2013, The Journal of clinical endocrinology and metabolism.

Serum phosphate is related to adiposity in healthy adults

I. Reid, G. Gamble, E. Billington, 2017, European journal of clinical investigation.

Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post‐menopausal osteoporosis

I. Reid, M. Evans, D. Wattie, 1997, Clinical endocrinology.

Four-year Results of a Phase 2 Study of the Cathepsin K Inhibitor Odanacatib in Postmenopausal Women with Low Bone Mineral Density: Effects on Bone Mineral Density and Bone Turnover Markers

I. Reid, J. Eisman, P. Miller, 2011 .

Effect of a Three‐Day Course of Dexamethasone on Acute Phase Response Following Treatment With Zoledronate: A Randomized Controlled Trial

I. Reid, A. Horne, E. Billington, 2023, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of Intravenous Zoledronate on Bone Turnover and Bone Density Persist for at Least 11 Years in HIV‐Infected Men

I. Reid, G. Gamble, A. Grey, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Odanacatib anti-fracture efficacy and safety in postmenopausal women with osteoporosis: results from the phase III long-term odanacatib fracture trial

Zanchetta, D. Kiel, J. Reginster, 2015 .

Doctors won’t treat patients for conditions they don’t have

I. Reid, 2022, Osteoporosis International.

Effect of Zoledronate on Lower Respiratory Infections in Older Women: Secondary Analysis of a Randomized Controlled Trial

I. Reid, G. Gamble, A. Horne, 2021, Calcified Tissue International.

Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.

I. Reid, G. Gamble, A. Grey, 2012, Bone.

Effects of Intravenous Zoledronate on Bone Turnover and BMD Persist for at Least 24 Months

I. Reid, K. Callon, A. Grey, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction

I. Reid, R. Ames, G. Gamble, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Comparison of dual-energy X-ray absorptiometry and conventional radiography for the detection of vertebral fractures.

I. Reid, G. Gamble, Ian R Reid, 2005, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Relationships between vascular calcification, calcium metabolism, bone density, and fractures

I. Reid, R. Ames, G. Gamble, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone Loss After Denosumab: Only Partial Protection with Zoledronate

I. Reid, G. Gamble, A. Horne, 2017, Calcified Tissue International.

Testosterone Levels Following Decreases in Serum Osteocalcin

I. Reid, A. Grey, M. Bolland, 2013, Calcified Tissue International.

High peripheral and axial bone densities in a postmenopausal woman with untreated hypoparathyroidism.

I. Reid, I. Holdaway, B. Orr-Walker, 1990, Postgraduate medical journal.

Calcium supplementation does not affect CRP levels in postmenopausal women – a randomized controlled trial

I. Reid, R. Ames, G. Gamble, 2006, Osteoporosis International.

What is the risk of cardiovascular events in osteoporotic patients treated with romosozumab?

I. Reid, 2022, Expert opinion on drug safety.

Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy

I. Reid, G. Gamble, A. Grey, 2019, Calcified Tissue International.

Once‐yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial

S. Cummings, S. Boonen, J. Cauley, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Skeletal Effects of Amylin and Related Peptides

I. Reid, J. Cornish, 1999 .

Authors’ reply

A. Avenell, I. Reid, J. Baron, 2010, BMJ : British Medical Journal.

The vitamin D testing rate is again rising, despite new MBS testing criteria.

I. Reid, L. Gordon, R. Neale, 2020, The Medical journal of Australia.

Erratum: Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long‐term continuation on bone turnover and fracture risk—A perspective

S. Boonen, I. Reid, P. Sambrook, 2012 .

Erratum: Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long‐term continuation on bone turnover and fracture risk—A perspective

S. Boonen, I. Reid, P. Sambrook, 2012 .

Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention

S. Lord, C. Inderjeeth, I. Reid, 2010, The Medical journal of Australia.

Treatment of Paget’s Disease of Bone with Denosumab: Case Report and Literature Review

I. Reid, Sonakshi Sharma, R. Kalluru, 2016, Calcified Tissue International.

Lateral Bone Densitometry Is a More Sensitive Indicator of Glucocorticoid-Induced Bone Loss

I. Reid, M. Evans, J. Stapleton, 1993 .

Preventing glucocorticoid-induced osteoporosis

I. Reid, 2000, Zeitschrift für Rheumatologie.

Towards a trial-based definition of vitamin D deficiency.

I. Reid, 2016, The lancet. Diabetes & endocrinology.

Faculty Opinions recommendation of DHEA in elderly women and DHEA or testosterone in elderly men.

I. Reid, 2006 .

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

Jacques P. Brown, J. Kaufman, I. Reid, 2003 .

Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study

R. Rizzoli, I. Reid, C. Benhamou, 2016, Osteoporosis International.

The effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

S. Cummings, S. Boonen, J. Cauley, 2011 .

No Reduction in Circulating Preosteoclasts 18 Months after Treatment with Zoledronate: Analysis from a Randomized Placebo Controlled Trial

I. Reid, J. Cornish, N. Dalbeth, 2012, Calcified Tissue International.

Monitoring Osteoporosis Therapy

I. Reid, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Osteonecrosis of the jaw and bisphosphonates

I. Reid, A. Grey, M. Bolland, 2006, BMJ : British Medical Journal.

Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates

I. Reid, A. Horne, B. Mihov, 2018, Calcified Tissue International.

Inositol Lipids in Cell Signaling by Parathyroid Hormone

I. Reid, M. Goligorsky, K. Hruska, 1989 .

Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up

I. Reid, A. Horne, B. Mihov, 2019, Calcified Tissue International.

Membrane potential and cation content of osteoblast‐like cells (UMR 106) assessed by fluorescent dyes

I. Reid, K. Hruska, L. Avioli, 1987, Journal of cellular physiology.

The randomised controlled trial to meta-analysis ratio: original data versus systematic reviews in the medical literature.

I. Reid, A. Grey, M. Bolland, 2007, The New Zealand medical journal.

Re: The calcium scare: what would Austin Bradford Hill have thought?

I. Reid, A. Grey, M. Bolland, 2011, Osteoporosis International.

Increased prescription of antidepressants shows correction of inadequate duration of treatment of depression

I. Reid, S. MacGillivray, I. Cameron, 2014, BMJ : British Medical Journal.

Subgroup analysis for the risk of cardiovascular disease with calcium supplements

I. Reid, G. Gamble, A. Grey, 2013, BoneKEy reports.

PTH (parathyroid hormone) elevates inositol polyphosphates and diacylglycerol in a rat osteoblast-like cell line

I. Reid, K. Hruska, L. Avioli, 1988 .

Adrenomedullin—a regulator of bone formation

I. Reid, J. Cornish, D. Naot, 2003, Regulatory Peptides.

Systemic administration of adrenomedullin(27-52) increases bone volume and strength in male mice.

I. Reid, J. Cornish, K. Callon, 2001, The Journal of endocrinology.

Vitamin D: the more we know, the less we know.

I. Reid, M. Holick, R. Thadhani, 2015, Clinical chemistry.

The effects of hydrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse calvaria

I. Reid, D. Gray, J. M. Katz, 2007, Calcified Tissue International.

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

Daniel L. Koller, D. Kiel, A. Uitterlinden, 2012, Nature Genetics.

Osteonecrosis of the jaw

I. Reid, T. Cundy, 2008, Skeletal Radiology.

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

Daniel L. Koller, D. Kiel, A. LaCroix, 2012, Nature Genetics.

Calcium and Cardiovascular Disease

I. Reid, M. Bolland, Sarah M Birstow, 2017, Endocrinology and metabolism.

Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice.

I. Reid, J. Cornish, K. Callon, 1998, The American journal of physiology.

Low serum osteocalcin levels in glucocorticoid-treated asthmatics.

I. Reid, T. Fraser, A. Davies, 1986, The Journal of clinical endocrinology and metabolism.

Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo.

I. Reid, J. Cornish, K. Callon, 1997, The American journal of physiology.

Parathyroid hormone-related protein-(107-139) inhibits bone resorption in vivo.

I. Reid, J. Cornish, K. Callon, 1997, Endocrinology.

Zoledronate Slows Weight Loss and Maintains Fat Mass in Osteopenic Older Women: Secondary Analysis of a Randomized Controlled Trial

I. Reid, G. Gamble, A. Horne, 2020, Calcified Tissue International.

Therapy of osteoporosis: calcium, vitamin D, and exercise.

I. Reid, 1996, The American journal of the medical sciences.

Parathyroid hormone related peptide(107-139) inhibits bone resorption in vivo.

I. Reid, J. Cornish, K. Callon, 1996 .

Alendronate in the treatment of Paget's disease of bone.

I. Reid, E. Siris, 1999, International journal of clinical practice. Supplement.

Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1.

I. Reid, J. Cornish, K. Callon, 2004, Biochemical and biophysical research communications.

Relationship Between Changes in Serum Urate and Bone Mineral Density During Treatment with Thiazide Diuretics: Secondary Analysis from a Randomized Controlled Trial

I. Reid, G. Gamble, N. Dalbeth, 2016, Calcified Tissue International.

Vitamin D insufficiency and health outcomes over 5 y in older women.

I. Reid, R. Ames, G. Gamble, 2010, The American journal of clinical nutrition.

The investigation of hypercalcaemia

I. Reid, 1994, Clinical endocrinology.

Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo.

I. Reid, H. Baker, E. Baker, 2004, Endocrinology.

Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

Jacques P. Brown, C. Cooper, M. Bhandari, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Osteoporosis treatment (ECTS 2013)

I. Reid, 2013 .

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

A. Avenell, I. Reid, J. Baron, 2010, BMJ : British Medical Journal.

Actions of fibroblast growth factor-8 in bone cells in vitro.

I. Reid, J. Cornish, K. Callon, 2009, American journal of physiology. Endocrinology and metabolism.

MMRF May 05 Booklet_New.qxd

I. Reid, J. Cornish, A. Grey, 2005 .

Amylin and adrenomedullin - novel promotors of osteoblast survival from apoptosis

I. Reid, J. Cornish, K. Callon, 2000 .

Effects of OPG and rankl in murine bone marrow and organ culture systems

I. Reid, J. Cornish, K. Callon, 2000 .

Meta-analysis of the effects of vitamin D supplements on bone mineral density in adults

I. Reid, A. Grey, M. Bolland, 2013 .

Effect of osteoporosis treatment on mortality: a meta-analysis.

I. Reid, G. Gamble, A. Grey, 2010, The Journal of clinical endocrinology and metabolism.

What diseases are causally linked to vitamin D deficiency?

I. Reid, 2015, Archives of Disease in Childhood.

25‐Hydroxyvitamin D Threshold for the Effects of Vitamin D Supplements on Bone Density: Secondary Analysis of a Randomized Controlled Trial

I. Reid, G. Gamble, W. Fraser, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Relationships between vascular calcification, calcium metabolism, bone density, and fractures

I. Reid, R. Ames, G. Gamble, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

THURSDAY CONCURRENT SESSION # 1 S-1 . Odanacatib Efficacy and Safety in Postmenopausal Women with Osteoporosis : 5-Year Data from the Extension of the Phase 3 Long-term Odanacatib Fracture Trial ( LOFT )

D. Kiel, J. Manson, J. Cauley, 2016 .

Does degree of baldness influence vitamin D status?

I. Reid, R. Ames, A. Grey, 2008, The Medical journal of Australia.

Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2005, The Journal of clinical endocrinology and metabolism.

Depot medroxyprogesterone and bone density

I. Reid, T. Cundy, 1994, BMJ.

No Effect of NSAID Use on Efficacy of Zoledronate: A Post Hoc Analysis of a Randomized Trial in Osteopenic Older Women

I. Reid, A. Horne, S. Bastin, 2023, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?

S. Cummings, S. Boonen, J. Cauley, 2014, The Journal of clinical endocrinology and metabolism.

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

S. Cummings, C. Christiansen, I. Reid, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men.

I. Reid, R. Ames, G. Gamble, 2008, Archives of internal medicine.

Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

R. Doughty, I. Reid, R. Ames, 2008, BMJ : British Medical Journal.

Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease

I. Reid, J. Adachi, P. Miller, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bisphosphonate holidays

I. Reid, 2021, Drug and Therapeutics Bulletin.